First Merchants Corp’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $3.09M | Sell |
8,521
-351
| -4% | -$120K | 0.11% | 147 |
|
|
2026
Q1 | $3.12M | Sell |
8,872
-741
| -8% | -$264K | 0.12% | 139 |
|
|
2025
Q4 | $3.15M | Sell |
9,613
-92
| -0.9% | -$29.2K | 0.12% | 139 |
|
|
2025
Q3 | $2.74M | Sell |
9,705
-729
| -7% | -$211K | 0.1% | 150 |
|
|
2025
Q2 | $2.91M | Sell |
10,434
-1,450
| -12% | -$411K | 0.11% | 142 |
|
|
2025
Q1 | $3.7M | Sell |
11,884
-377
| -3% | -$111K | 0.15% | 136 |
|
|
2024
Q4 | $3.2M | Buy |
12,261
+52
| +0.4% | +$15.4K | 0.12% | 144 |
|
|
2024
Q3 | $3.93M | Sell |
12,209
-156
| -1% | -$51K | 0.15% | 137 |
|
|
2024
Q2 | $3.86M | Sell |
12,365
-47
| -0.4% | -$13.8K | 0.16% | 134 |
|
|
2024
Q1 | $3.53M | Sell |
12,412
-595
| -5% | -$174K | 0.27% | 104 |
|
|
2023
Q4 | $3.75M | Sell |
13,007
-251
| -2% | -$68.4K | 0.31% | 98 |
|
|
2023
Q3 | $3.56M | Sell |
13,258
-1,786
| -12% | -$446K | 0.32% | 97 |
|
|
2023
Q2 | $3.34M | Sell |
15,044
-2,959
| -16% | -$687K | 0.28% | 102 |
|
|
2023
Q1 | $4.35M | Sell |
18,003
-1,093
| -6% | -$268K | 0.39% | 89 |
|
|
2022
Q4 | $5.02M | Sell |
19,096
-3,236
| -14% | -$867K | 0.46% | 76 |
|
|
2022
Q3 | $5.03M | Sell |
22,332
-82
| -0.4% | -$19.9K | 0.5% | 65 |
|
|
2022
Q2 | $5.45M | Sell |
22,414
-68
| -0.3% | -$16.7K | 0.54% | 61 |
|
|
2022
Q1 | $5.44M | Buy |
22,482
+122
| +0.5% | +$28K | 0.45% | 72 |
|
|
2021
Q4 | $5.03M | Sell |
22,360
-3,676
| -14% | -$776K | 0.39% | 81 |
|
|
2021
Q3 | $5.54M | Sell |
26,036
-8,828
| -25% | -$2.03M | 0.35% | 72 |
|
|
2021
Q2 | $8.5M | Buy |
34,864
+345
| +1% | +$84.9K | 0.55% | 41 |
|
|
2021
Q1 | $8.59M | Buy |
34,519
+2,380
| +7% | +$568K | 0.57% | 39 |
|
|
2020
Q4 | $7.39M | Buy |
32,139
+3,243
| +11% | +$748K | 0.51% | 51 |
|
|
2020
Q3 | $7.34M | Buy |
28,896
+813
| +3% | +$201K | 0.56% | 37 |
|
|
2020
Q2 | $6.62M | Buy |
28,083
+1,374
| +5% | +$313K | 0.56% | 40 |
|
|
2020
Q1 | $5.41M | Buy |
26,709
+897
| +3% | +$196K | 0.7% | 44 |
|
|
2019
Q4 | $6.22M | Buy |
25,812
+1,035
| +4% | +$228K | 0.64% | 51 |
|
|
2019
Q3 | $4.79M | Buy |
24,777
+2,265
| +10% | +$435K | 0.51% | 65 |
|
|
2019
Q2 | $4.15M | Buy |
22,512
+839
| +4% | +$150K | 0.66% | 56 |
|
|
2019
Q1 | $4.12M | Buy |
21,673
+3,775
| +21% | +$721K | 0.66% | 56 |
|
|
2018
Q4 | $3.48M | Buy |
17,898
+454
| +3% | +$88.6K | 0.67% | 55 |
|
|
2018
Q3 | $3.62M | Buy |
17,444
+369
| +2% | +$72.7K | 0.59% | 60 |
|
|
2018
Q2 | $3.15M | Buy |
17,075
+4,003
| +31% | +$708K | 0.55% | 63 |
|
|
2018
Q1 | $2.23M | Buy |
13,072
+11,648
| +818% | +$2.14M | 0.37% | 81 |
|
|
2017
Q4 | $248K | Buy |
1,424
+149
| +12% | +$26.4K | 0.04% | 201 |
|
|
2017
Q3 | $238K | Sell |
1,275
-25
| -2% | -$4.43K | 0.04% | 203 |
|
|
2017
Q2 | $224K | Hold |
1,300
| – | – | 0.06% | 147 |
|
|
2017
Q1 | $213K | Sell |
1,300
-87
| -6% | -$14.5K | 0.06% | 147 |
|
|
2016
Q4 | $203K | Sell |
1,387
-658
| -32% | -$99K | 0.06% | 150 |
|
|
2016
Q3 | $341K | Buy |
+2,045
| New | +$346K | 0.11% | 136 |
|
Other funds holding AMGN
SP
CRM
SW
AWA
CNB
P
First Merchants Corp's AMGN Position: Q2 2026 in Review
First Merchants Corp reduced its Amgen (AMGN) stake by 4% in Q2 2026, selling an estimated $120K and leaving 8,521 shares worth $3.09M. The position accounts for 0.11% of the portfolio, ranked #147.
First Merchants Corp first reported a position in AMGN in Q3 2016 and has held it in 40 quarters since. The position peaked at $8.59M in Q1 2021. 527 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.
- First Merchants Corp held 8,521 shares of Amgen worth $3.09M as of Q2 2026.
- First Merchants Corp sold 351 Amgen shares in Q2 2026, an estimated $120K.
- Amgen made up 0.11% of First Merchants Corp's portfolio in Q2 2026, its #147 holding.
- First Merchants Corp first reported a position in Amgen in Q3 2016 and has held it in 40 quarters since.
- First Merchants Corp's Amgen position peaked at $8.59M in Q1 2021.
- 527 funds tracked by Wall St. Rank held Amgen as of Q2 2026.
Based on First Merchants Corp's 13F filing for Q2 2026, filed 15 Jul 2026.